Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectrums. June 2018, 23 (3): 187–191. PMID 29954475. S2CID 49599226. doi:10.1017/S1092852918001013.
Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. The American Journal of Psychiatry. October 2017, 174 (10): 927–942. PMID 28541090. S2CID 27256686. doi:10.1176/appi.ajp.2017.16121358.
Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena?. The British Journal of Psychiatry. 1996-10, 169 (4): 459–67. PMID 8894197. doi:10.1192/bjp.169.4.459.
Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectrums. June 2018, 23 (3): 187–191. PMID 29954475. S2CID 49599226. doi:10.1017/S1092852918001013.
Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. The American Journal of Psychiatry. October 2017, 174 (10): 927–942. PMID 28541090. S2CID 27256686. doi:10.1176/appi.ajp.2017.16121358.
Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena?. The British Journal of Psychiatry. 1996-10, 169 (4): 459–67. PMID 8894197. doi:10.1192/bjp.169.4.459.
Chan-Ob T, Boonyanaruthee V. Meditation in association with psychosis. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet. 1999-09, 82 (9): 925–30. PMID 10561951.
Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectrums. June 2018, 23 (3): 187–191. PMID 29954475. S2CID 49599226. doi:10.1017/S1092852918001013.
Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. The American Journal of Psychiatry. October 2017, 174 (10): 927–942. PMID 28541090. S2CID 27256686. doi:10.1176/appi.ajp.2017.16121358.